<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: skin disease</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>'Slippery slope' fears for legal euthanasia of very sick newborns unfounded</title>
   	 <description>Fears that legalising euthanasia for very sick newborns would prompt the start of a &quot;slippery slope&quot; and lead to abuse of the option have proved groundless, says the architect of a dedicated protocol used by doctors in The Netherlands, in a special issue of the Journal of Medical Ethics.</description>
     <link>http://medicalxpress.com/news/2013-05-slippery-slope-legal-euthanasia-sick.html</link>
	 <category>Other</category>
	 <pubDate>Wed, 01 May 2013 18:30:02 EST</pubDate>
	 <guid isPermaLink="false">news286645537</guid>
	 
</item>
<item>
     <title>African Programme for Onchocerciasis Control 1995—2015: Model-estimated health impact and cost</title>
   	 <description>A relatively inexpensive program set up to combat river blindness, an infectious disease, has resulted in major health improvements in Africa, shows a study conducted by Erasmus University Medical Center researchers. The study, due to be published January 31 in PLOS Neglected Tropical Diseases, shows that US$250 million helped cure or prevent blindness, skin disease, severe itching, and other symptoms in millions of people. In collaboration with the Management of the African Programme for Onchocerciasis Control (APOC), the researchers calculated the health impact of APOC.</description>
     <link>http://medicalxpress.com/news/2013-01-african-programme-onchocerciasis-model-estimated-health.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 31 Jan 2013 17:00:04 EST</pubDate>
	 <guid isPermaLink="false">news278872210</guid>
	 
</item>
<item>
     <title>Pathogenic bacteria adhering to the human vascular wall triggers vascular damage during meningococcal sepsis</title>
   	 <description>Researchers at the Paris Cardiovascular Research Center (PARCC) have shown how adhesion of Neisseria (N.) meningitidis to human microvessels in a humanized mouse model leads to the characteristic cutaneous lesions of meningococcal sepsis. This work, published on January 24 in the Open Access journal PLOS Pathogens, is an important demonstration of the direct role of adhesion, specifically Type IV pili mediated adhesion, plays in the development of the disease.</description>
     <link>http://medicalxpress.com/news/2013-01-pathogenic-bacteria-adhering-human-vascular.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 24 Jan 2013 17:00:11 EST</pubDate>
	 <guid isPermaLink="false">news278265511</guid>
	 
</item>
<item>
     <title>Small peptide ameliorates autoimmune skin blistering disease in mice</title>
   	 <description>Pemphigus vulgaris is a life-threatening autoimmune skin disease that is occurs when the body's immune system generates antibodies that target proteins in the skin known as desomogleins. Desmogleins help to form the adhesive bonds that hold skin cells together and keep the skin intact. Currently, pemphigus vulgaris is treated by long-term immune suppression; however, this can leave the patient susceptible to infection.</description>
     <link>http://medicalxpress.com/news/2013-01-small-peptide-ameliorates-autoimmune-skin.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 09 Jan 2013 12:00:06 EST</pubDate>
	 <guid isPermaLink="false">news276953717</guid>
	 
</item>
<item>
     <title>Adalimumab relieves hidradenitis suppurativa</title>
   	 <description>(HealthDay)—For patients with moderate-to-severe hidradenitis suppurativa (HS), a chronic skin disease characterized by painful abscesses, nodules, and draining fistulas in the axilla and groin, treatment with once-weekly adalimumab is associated with improvements in pain and inflammation, according to a study published online Dec. 17 in the Annals of Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2012-12-adalimumab-relieves-hidradenitis-suppurativa.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Tue, 18 Dec 2012 18:07:14 EST</pubDate>
	 <guid isPermaLink="false">news275076428</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/adalimumabre.jpg" width="90" height="90" />
</item>
<item>
     <title>Kids with psoriasis likely to be obese or overweight</title>
   	 <description>The largest study of physician-treated children with psoriasis around the world shows children with the skin disease are about twice as likely to be overweight or obese as children who don't have the disease, according to new Northwestern Medicine research.</description>
     <link>http://medicalxpress.com/news/2012-11-kids-psoriasis-obese-overweight.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 19 Nov 2012 16:00:27 EST</pubDate>
	 <guid isPermaLink="false">news272541294</guid>
	 
</item>
<item>
     <title>Engineering a better hip implant</title>
   	 <description>University of Iowa researchers have determined that thigh size in obese people is a reason their hip implants are more likely to fail.</description>
     <link>http://medicalxpress.com/news/2012-09-hip-implant.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 18 Sep 2012 15:09:27 EST</pubDate>
	 <guid isPermaLink="false">news267199717</guid>
	 
</item>
<item>
     <title>Drugs are first to topically deliver gene therapy via commercial moisturizers for skin disease treatment</title>
   	 <description>&quot;Getting under your skin&quot; takes on a brave new meaning thanks to Northwestern University research that could transform gene regulation.</description>
     <link>http://medicalxpress.com/news/2012-07-drugs-topically-gene-therapy-commercial.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 02 Jul 2012 15:00:05 EST</pubDate>
	 <guid isPermaLink="false">news260456186</guid>
	 
</item>
<item>
     <title>Epidemiology of rosacea described in United Kingdom</title>
   	 <description>(HealthDay) -- The incidence of rosacea in the United Kingdom is 1.65 per 1,000 person-years, with alcohol consumption linked to a modest increase in risk and current smoking linked to an decreased risk, according to a study published online May 5 in the British Journal of Dermatology.</description>
     <link>http://medicalxpress.com/news/2012-05-epidemiology-rosacea-kingdom.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 21 May 2012 04:40:01 EST</pubDate>
	 <guid isPermaLink="false">news256791790</guid>
	 
</item>
<item>
     <title>Skin experts call for assessment of new nickel-plated coins</title>
   	 <description>In a letter published today on bmj.com, authors from St John's Institute of Dermatology and the Royal Hallamshire Hospital in Sheffield look at The Treasury's plans to introduce Royal Mint nickel-plated coins.</description>
     <link>http://medicalxpress.com/news/2012-04-skin-experts-nickel-plated-coins.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 20 Apr 2012 02:10:02 EST</pubDate>
	 <guid isPermaLink="false">news254105068</guid>
	 
</item>
<item>
     <title>Patients with skin disease deserve better treatment</title>
   	 <description>Better access to specialists, more relevant training for health professionals and the introduction of reliable data to manage services effectively &amp;#151; these are the recommendations of a major review carried out by experts at The University of Nottingham into health care for patients with skin disease.</description>
     <link>http://medicalxpress.com/news/2012-04-patients-skin-disease-treatment.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 13 Apr 2012 08:22:12 EST</pubDate>
	 <guid isPermaLink="false">news253524124</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-patientswith.jpg" width="90" height="90" />
</item>
<item>
     <title>New medication, surgery may offer relief for patients with psoriatic arthritis</title>
   	 <description>Medications or biologic agents that target T-cells, white blood cells involved in the body's immune system, appear to offer significant benefit to patients suffering from psoriatic arthritis (PsA), a type of arthritis that affects up to 48 percent of patients with the skin disease psoriasis, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS). About 7.5 million Americans &amp;#150; roughly 2.2 percent of the population &amp;#150; have psoriasis, an autoimmune disease that causes red, flaky skin.</description>
     <link>http://medicalxpress.com/news/2012-01-medication-surgery-relief-patients-psoriatic.html</link>
	 <category>Surgery</category>
	 <pubDate>Wed, 18 Jan 2012 13:03:54 EST</pubDate>
	 <guid isPermaLink="false">news246114217</guid>
	 
</item>
<item>
     <title>Research confirms novel strategy in fight against infectious diseases</title>
   	 <description>New research shows that infectious disease-fighting drugs could be designed to block a pathogen's entry into cells rather than to kill the bug itself.</description>
     <link>http://medicalxpress.com/news/2012-01-strategy-infectious-diseases.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 09 Jan 2012 15:00:10 EST</pubDate>
	 <guid isPermaLink="false">news245325555</guid>
	 
</item>
<item>
     <title>Henry Ford Hospital first in United States to offer MKTP surgery as treatment option for vitiligo</title>
   	 <description>Henry Ford Hospital is the first in the country to offer skin transplant surgery as part of its treatment portfolio for patients with the skin disease vitiligo.</description>
     <link>http://medicalxpress.com/news/2011-10-henry-ford-hospital-states-mktp.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 25 Oct 2011 12:27:39 EST</pubDate>
	 <guid isPermaLink="false">news238764435</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/henryfordhos.jpg" width="90" height="90" />
</item>
<item>
     <title>Immune cell plays dual role in allergic skin disease</title>
   	 <description>(Medical Xpress) -- An immune cell involved in initiating the symptoms of an allergic skin reaction may play an equally, or perhaps more important, role in suppressing the reaction once it becomes chronic. This finding in mice could have future implications for the treatment of atopic dermatitis, a chronic inflammatory skin disease that affects an estimated 10 to 20 percent of infants and young children. The research is by investigators at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health.</description>
     <link>http://medicalxpress.com/news/2011-10-immune-cell-dual-role-allergic.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 18 Oct 2011 10:10:25 EST</pubDate>
	 <guid isPermaLink="false">news238151413</guid>
	 
</item>
<item>
     <title>Relief from red, itchy skin: Unraveling the secrets of vitamin D</title>
   	 <description>Vitamin D helps to reduce the inflammation associated with psoriasis, a common skin condition that causes red, itchy patches on the skin, shows a new study. </description>
     <link>http://medicalxpress.com/news/2011-05-relief-red-itchy-skin-unraveling.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 12 May 2011 07:02:31 EST</pubDate>
	 <guid isPermaLink="false">news224402524</guid>
	 
</item>


</channel>
</rss>
